Skip to main content

Table 1 Baseline demographic and tumor characteristics of married and unmarried patients

From: Effect of marital status on the survival outcomes of cervical cancer: a retrospective cohort study based on SEER database

 

Before PSM

After PSM

Characteristics

Total

n = 21,148(%)

married

n = 10,603(%)

unmarried

n = 10,545(%)

P value

Total

n = 14,412(%)

married

n = 7206(%)

unmarried

n = 7206(%)

P value

Year of diagnosis

   

< 0.001

   

1.00

 1975–2000

11,720(55.4%)

6101(57.5%)

5619(53.3%)

 

7780(54.0%)

3890(54.0%)

3890(54.0%)

 

 2001–2017

9428(44.6%)

4502(42.5%)

4926(46.7%)

 

6632(46.0%)

3316(46.0%)

3316(46.0%)

 

age

   

< 0.001

   

1.00

 < 45

9000(42.6%)

5035(47.5%)

3965(37.6%)

 

6502(45.1%)

3251(45.1%)

3251(45.1%)

 

 45–59

6051(28.6%)

3349(31.6%)

2702(25.6%)

 

4144(28.8%)

2072(28.8%)

2072(28.8%)

 

 ≥ 60

6097(28.8%)

2219(20.9%)

3878(36.8%)

 

3766(26.1%)

1883(26.1%)

1883(26.1%)

 

Race

   

< 0.001

   

1.00

 White

16,092(76.1%)

8345(78.7%)

7747(73.5%)

 

11,678(81.0%)

5839(81.0%)

5839(81.0%)

 

 Black

2241(10.6%)

646(6.1%)

1595(15.1%)

 

1046(7.3%)

523(7.3%)

523(7.3%)

 

 Others

2815(13.3%)

1612(15.2%)

1203(11.4%)

 

1688(11.7%)

844(11.7%)

844(11.7%)

 

Histologic type

   

< 0.001

   

1.00

 SCC

14,314(67.6%)

6776(63.9%)

7538(71.5%)

 

10,374(72.0%)

5187(72.0%)

5187(72.0%)

 

 AC

4204(19.9%)

2460(23.2%)

1744(16.65%)

 

2522(17.5%)

1261(17.5%)

1261(17.5%)

 

 Other

2630(12.4%)

1367(12.9%)

1263(12.0%)

 

1516(10.5%)

758(10.5%)

758(10.5%)

 

Grade

   

< 0.001

   

1.00

 Well

3044(14.4%)

1739(16.4%)

1305(12.4%)

 

1900(13.2%)

950(13.2%)

950(13.2%)

 

 Moderately

8739(41.3%)

4360(41.1%)

4379(41.5%)

 

6238(43.3%)

3119(43.3%)

3119(43.3%)

 

 Poorly/Undiff

9365(44.3%)

4505(42.5%)

4861(46.1%)

 

6274(43.5%)

3137(43.5%)

3137(43.5%)

 

Stage

   

< 0.001

   

1.00

 Localized

10,432(49.3%)

5746(54.2%)

4686(44.54%)

 

7548(52.4%)

3774(52.4%)

3774(52.4%)

 

 Regional

8385(39.6%)

3834(36.2%)

4551(43.2%)

 

5624(39.0%)

2812(39.0%)

2812(39.0%)

 

 Distant

2331(11.0%)

1023(9.6%)

1308(12.4%)

 

1240(8.6%)

620(8.6%)

620(8.6%)

 

Regional nodes

   

0.004

   

1.00

 Positive

1716(8.1%)

918(8.7%)

798(7.6%)

 

1036(7.2%)

518(7.2%)

518(7.2%)

 

 Negative

19,432(91.9%)

9685(91.3%)

9747(92.4%)

 

13,376(92.8%)

6688(92.8%)

6688(92.8%)

 

Surgery

   

< 0.001

   

1.00

 Yes

13,076(61.8%)

7233(68.2%)

5843(55.4%)

 

9134(63.4%)

4567(63.4%)

4567(63.4%)

 

 No

8072(38.2%)

3370(31.8%)

4702(44.6%)

 

5278(36.6%)

2639(36.6%)

2639(36.6%)

 

Radiotherapy

   

< 0.001

    

 Yes

12,531(59.3%)

5906(55.7%)

6625(62.8%)

 

8500(59.0%)

4250(59.0%)

4250(59.0%)

1.00

 No

8617(40.7%)

4697(44.3%)

3920(37.2%)

 

5912(41.0%)

2956(41.0%)

2956(41.0%)

 

Chemotherapy

   

< 0.001

   

1.00

 Yes

6117(28.9%)

2886(27.2%)

3231(30.6%)

 

4122(28.6%)

2061(28.6%)

2061(28.6%)

 

 No

15,031(71.1%)

7717(72.8%)

7314(69.4%)

 

10,290(71.4%)

5145(71.4%)

5145(71.4%)

 
  1. PSM, Propensity score matching; SCC, Squamous Cell Carcinoma; AC, Adenocarcinoma